Name: Oleyl-PSar15
SKU: PSR1930
Availability: InStock

Grouped product items

Nombre

Unité de vente

Prix

SKU

Disponibilité

25 mg

290,00 €

PSR1930.0025

100 mg

1 000,00 €

PSR1930.0100

Fiches de données de sécurité

description

Nucleic acids have emerged in recent years as promising drug candidates for a wide range of diseases, as demonstrated by the development of mRNA vaccines to combat the Covid-19 pandemic. As nucleic acids are unable to pass physiological barriers, novel tools for packaging and delivery are required, especially since the frequently used polyethylene glycol may induce the generation of anti-PEG antibodies, leading to immunogenicity and allergic reactions. Iris Biotech offers a selection of innovative lipidated PSar and PGA-based polyamino acids for improved drug delivery.

SURPAX™ Technology (Surface Pacifying Excipient) was originally designed for protein stabilization but has found additional application as a shielding lipid in LNP formulations. This product shows superior properties for antibody and protein stability, does not impact binding, and maintains activities of mAB to targets. Biocompatibility has been tested vs body weight gain, vein tolerance, biochemical profile, and hematology.

references

US Patent 11,692,099

* Disclaimer

We refer to our general terms and conditions.
All information contained in our webshop is compiled to the best of our knowledge.
Prices and product availability are subject to change and require reconfirmation. Please contact us for further information.